Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies

NCT01781429 is registered in ClinicalTrials.gov with BioMed Valley Discoveries, Inc as lead sponsor.

NCT NCT01781429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01781429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies
Lead sponsor
BioMed Valley Discoveries, Inc
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2013
Completion date
September 30, 2018
Enrollment
136 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors